Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 08, 2026
Hovione Holding AG has appointed Stefan Doboczky as chief executive officer, effective April 1, 2027, moving the company’s current board chairman into its top operating role.
read more
Tuesday, September 08, 2026
Charles River Laboratories has brought a fully automated production suite for Endosafe bacterial endotoxin testing cartridges into full operation, increasing manufacturing capacity and adding inspection and digital-traceability functions.
read more
Tuesday, September 08, 2026
Onyx Scientific will invest more than £1.5 million, or about $2 million, to expand commercial active pharmaceutical ingredient manufacturing capacity at its Sunderland, United Kingdom, facility.
read more
Thursday, September 03, 2026
The Advanced Research Projects Agency for Health has selected five teams for a program intended to develop automated, distributed manufacturing systems for individualized RNA-based genetic medicines, with up to $125 million available for research and...
read more
Thursday, September 03, 2026
Lifecore Biomedical has signed an agreement with an undisclosed global pharmaceutical company to transfer manufacturing of a currently marketed injectable drug product, adding what the company expects could become one of its largest commercial ...
read more
Thursday, September 03, 2026
Northway Biotech has opened a $72 million cell-therapy and personalized-medicine contract development and manufacturing facility in Vilnius, Lithuania, expanding its capacity to develop and produce advanced therapies.
read more
Thursday, September 03, 2026
Fortrea Holdings has agreed to acquire the Early Phase Services division of Worldwide Clinical Trials in an all-cash transaction valued at about $45 million, adding a Texas clinical pharmacology unit, bioanalytical laboratory and biospecimen storage ...
read more
Tuesday, September 01, 2026
Evonik will invest more than 150 million Canadian dollars, or about $109 million, to build a new good manufacturing practice drug-product facility in Vancouver, Canada, expanding its capacity for lipid-based drug delivery products including vaccines,...
read more
Tuesday, September 01, 2026
Andelyn Biosciences has been selected by Genprex Inc. to support manufacturing scale-up for an adeno-associated virus-based gene therapy program being developed for Type 1 and Type 2 diabetes.
read more
Tuesday, September 01, 2026
Informa Markets has announced the finalists for the CPHI Pharma Awards 2026, recognizing outstanding achievements across companies and individuals pushing the boundaries of science and technology to advance global healthcare.
read more
Tuesday, September 01, 2026
Samsung Biologics has published the formal prospectus for its planned acquisition of PolyPeptide Group AG, offering about $55.70 in cash per share in a transaction that values the Swiss peptide manufacturer’s equity at approximately $1.83 billion.
read more
Thursday, August 27, 2026
4basebio and Genezen have expanded a non-exclusive collaboration intended to give cell and gene therapy developers access to synthetic, cell-free DNA for viral vector development and clinical programs.
read more
Thursday, August 27, 2026
Artis BioSolutions has launched a Genetic Medicines Center of Excellence in Bilbao, Spain, adding mRNA and lipid nanoparticle development and manufacturing capabilities to its platform for genetic medicines.
read more
Wednesday, August 26, 2026
Lonza has appointed Samanta Cimitan as chief commercial officer, senior vice president and a member of its Extended Executive Committee, creating a role intended to strengthen customer engagement and establish a unified commercial approach across the...
read more
Wednesday, August 26, 2026
Centrix Pharma Solutions has partnered with the University of Sussex on a £375,000 Knowledge Transfer Partnership aimed at using data analytics and predictive modeling to improve pharmaceutical product development.
read more